Study to Test Use of a Decision Aid in a Clinical Visit to Help Patients Choose a Diabetes Medication
NCT01293578 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 550
Last updated 2022-09-28
Summary
The goal of this study is to test the relative merits of a decision aid for diabetes medications that we have developed - Diabetes Medication Choice Cards- versus usual care in translating comparative effectiveness research (CER) into real world clinics. This study will involve about 20 primary care practice sites affiliated with Mayo Health System, Park Nicollet, or Hennepin County Medical Center. There will be no recruiting done at the Mayo Clinic.
Conditions
Interventions
- OTHER
-
Diabetes Medication Choice Cards
Clinician uses the Diabetes Medication Choice Cards to inform and engage patient in discussing the issues they find relevant in choosing a new diabetes medication.
Sponsors & Collaborators
- lead OTHER
Principal Investigators
-
Victor Montori, MD · Mayo Clinic
Study Design
- Allocation
- RANDOMIZED
- Purpose
- SUPPORTIVE_CARE
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2011-01-31
- Primary Completion
- 2015-06-30
- Completion
- 2015-06-30
Countries
- United States
Study Locations
More Related Trials
-
GSK189075, GW869682 Or Placebo In Type 2 Diabetic Patients
NCT00291356 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy of INCB013739 Plus Metformin Compared to Metformin Alone on Glycemic Control in Type 2 Diabetics
NCT00698230 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of Gemigliptin 50mg qd Added in Patients With Type 2 Diabetes Inadequately Controlled on Glimepiride and Metformin
NCT01990469 ·Status: COMPLETED ·Phase: PHASE3
-
Safety, Tolerability and Efficacy of ISIS-GCGRRx in Patients With Type 2 Diabetes
NCT02583919 ·Status: COMPLETED ·Phase: PHASE2
-
Mitiglinide in Combination With Metformin vs. Metformin Alone in Patients With Type 2 Diabetes Mellitus
NCT00519142 ·Status: COMPLETED ·Phase: PHASE3
-
Phase III Trial to Evaluate the Efficacy and Safety of Initial Combination Therapy With Gemigliptin 50mg q.d and Metformin q.d
NCT01787396 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Combination of Mitiglinide and Metformin on Glycemic Control in Patients With Type 2 Diabetes Mellitus
NCT01037842 ·Status: COMPLETED ·Phase: PHASE3
-
Study To Compare Single Dose Of Three Modified Release Formulations Of PF-04937319 With Immediate Release Material-Sparing-Tablet (IR MST) Formulation Previously Studied In Adults With Type 2 Diabetes Mellitus.
NCT02206607 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of GSK256073 in Subjects With Type 2 Diabetes Mellitus Who Are Being Treated With Metformin
NCT01376323 ·Status: COMPLETED ·Phase: PHASE2
-
Observational Study Gemigliptin in Patients Aged ≥ 65 Years With Type 2 Diabetes Mellitus
NCT05281029 ·Status: UNKNOWN
-
Chiglitazar Added to Metformin for Type 2 Diabetes
NCT04807348 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus Treated With a Stable Dose of Metformin
NCT00266253 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Two Doses of Oral HDV-Insulin and Placebo With Background Metformin Treatment in Patients With Type 2 Diabetes Mellitus
NCT00814294 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Precision Dosing of Metformin in Youth With T2D
NCT06120881 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Short-Term Glycemic Effects of Liquid Metformin vs Standard Tablets
NCT07300059 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
A Study to Assess the Safety, Tolerability and Glucose-Lowering Efficacy of MK-0893 in Participants With Type 2 Diabetes Mellitus (MK-0893-005)
NCT02004886 ·Status: COMPLETED ·Phase: PHASE2
-
DECIDE: A Comparative Effectiveness Trial of Metformin Versus Insulin for the Treatment of Gestational Diabetes
NCT06445946 ·Status: RECRUITING ·Phase: PHASE4
-
Evaluate the Safety and Tolerability of INCB019602 When Administered With Metformin in Patients With Type 2 Diabetes
NCT00698789 ·Status: TERMINATED ·Phase: PHASE2
-
Bioequivalence Study to Compare Empagliflozin/Linagliptin/Metformin HCL 25mg/5mg/1000mg Extended-Release Tablets Versus Trijardy® XR Extended Release Film Coated Tablets
NCT07213895 ·Status: COMPLETED ·Phase: PHASE1
-
Effect of Treatment With Metformin in Type 2 Diabetes Patients on Alternative Genes Splicing
NCT01349387 ·Status: COMPLETED ·Phase: NA
-
Assessing the Efficacy, Safety, and Tolerability of Met DR in Subjects With T2DM Over 12 Weeks
NCT01819272 ·Status: COMPLETED ·Phase: PHASE2
-
Trial to Evaluate the Efficacy on Glycemic Variability and Safety of Gemigliptin Compared With Dapagliflozin Added on Metformin Alone or Diabetes Medication Naïve Patient in Type 2 Diabetes Mellitus (Stable II Study)
NCT03202563 ·Status: COMPLETED ·Phase: PHASE4
-
A Study of the Safety and Efficacy of MK-3577 in Participants With Type 2 Diabetes Mellitus (MK-3577-009)
NCT00868790 ·Status: TERMINATED ·Phase: PHASE2
-
Effect of Metformin on Gut Peptides , Bile Acids and Lipid Profiles in Type 2 Diabetics
NCT01357876 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Tolerability and Efficacy of ISIS-GCGRRx in Type 2 Diabetes
NCT01885260 ·Status: COMPLETED ·Phase: PHASE2